Trademark Overview
On Wednesday, January 29, 2025, a trademark application was filed for IVANO BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the IVANO BIOSCIENCE trademark a serial number of 99022612. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, February 5, 2026. This trademark is owned by AB VALIDATION INC.. The IVANO BIOSCIENCE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Custom design and development of chemical reagents and biochemical assays; research and development in the fields of assays, biological selection, medical screening, medical diagnostic testing, medical diagnostic imaging, and medical diagnostics using biomimicry technology; biochemical analysis; biochemical research; biomedical research services; biomedical research services, namely, preparation of biological samples for testing and analysis in research laboratories; research and development in the medical biotechnology field
Biological assays for research purposes in the fields of biological and diagnostic testing; kits comprised of biological assays and reagents for research purposes in the fields of biological and diagnostic testing; laboratory assay kits comprised of assays and reagents for research purposes; single-cell organisms for research use; Chemical diagnostic reagents for industrial use, namely, for use in biomanufacturing processes; genetically modified cells for research use; genome editing reagents for research use; viral vectors for research use; protein in raw material form for scientific and medical research; peptide substrates for scientific research purposes; diagnostic preparations in the nature of peptide substrates, other than for medical or veterinary purposes; nucleic acid sequences, other than for medical or veterinary purposes, namely, aptamers for research use; media for single-cell organism culture for research use
Medical diagnostic reagents and assays for testing of body fluids; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases; genetically modified cells for medical use, namely, diagnostic and therapeutic use; genome editing reagents for medical use, namely, diagnostic and therapeutic use; protein arrays for medical diagnosis purposes; diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; synthetic peptides for the treatment of cancer, genetic disorders, viral and infectious diseases; nucleic acid sequences for medical and veterinary purposes, namely, aptamers for diagnostic and therapeutic use; media for single-cell organism culture for medical use; single-cell organisms for medical use, namely, diagnostic and therapeutic use
